Research graph
References from Therapy‐Associated Lineage Switch and Clonal Evolution in Refractory <i>NUP98</i> :: <i>NSD1</i> ‐Rearranged Acute Leukemia. Local targets link to admitted publications; unresolved targets remain external evidence.
The Menin‐MLL1 Interaction Is a Molecular Dependency in NUP98‐rearranged AML
10.1182/blood.2021012806 · 2022 · External reference
NUP98/NSD1 Characterizes a Novel Poor Prognostic Group in Acute Myeloid Leukemia With a Distinct HOX Gene Expression Pattern
10.1182/blood-2011-04-346643 · 2011 · External reference
Unresolved reference
2024 · External reference
Unresolved reference
2024 · External reference
Acute Erythroid Leukemia Is Enriched in NUP98 Fusions: A Report From the Children's Oncology Group
10.1182/bloodadvances.2020002712 · 2020 · External reference
Mechanistic Insights and Potential Therapeutic Approaches for NUP98‐Rearranged Hematologic Malignancies
10.1182/blood.2020007093 · 2020 · External reference
Pathologic, Cytogenetic, and Molecular Features of Acute Myeloid Leukemia With Megakaryocytic Differentiation: A Report From the Children's Oncology Group
10.1002/pbc.30251 · 2023 · External reference
NUP98 Is Rearranged in 3.8% of Pediatric AML Forming a Clinical and Molecular Homogenous Group With a Poor Prognosis
10.1038/leu.2016.267 · 2017 · External reference
Comprehensive Molecular and Clinical Characterization of NUP98 Fusions in Pediatric Acute Myeloid Leukemia
10.3324/haematol.2022.281653 · 2023 · External reference
NUP98/NSD1 and FLT3/ITD Coexpression Is More Prevalent in Younger AML Patients and Leads to Induction Failure: A COG and SWOG Report
10.1182/blood-2014-04-570929 · 2014 · External reference
The Landscape of NUP98 Rearrangements Clinical Characteristics and Treatment Response From 1491 Acute Leukemia Patients
10.1038/s41408-024-01066-y · 2024 · External reference
Genetics and Pathologic Landscape of Lineage Switch of Acute Leukemia During Therapy
10.1038/s41408-024-00983-2 · 2024 · External reference
Acute Leukemia of Ambiguous Lineage: The Known and the Uncertain
2026 · External reference
Project EVOLVE: An International Analysis of Postimmunotherapy Lineage Switch, an Emergent Form of Relapse in Leukemia
10.1182/blood.2024026655 · 2025 · External reference
Fusion Oncoproteins and Cooperating Mutations Define Disease Phenotypes in NUP98‐rearranged Leukemia
10.1182/blood.2025028993 · 2025 · External reference
Integrative Genomic Analysis of Adult Mixed Phenotype Acute Leukemia Delineates Lineage Associated Molecular Subtypes
10.1038/s41467-018-04924-z · 2018 · External reference
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
10.1007/s11912-024-01503-y · 2024 · External reference
Relapsed Acute Myeloid Leukemia in Children and Adolescents: Current Treatment Options and Future Strategies
10.1038/s41375-022-01619-9 · 2022 · External reference
Single‐cell RNA Sequencing Distinctly Characterizes the Wide Heterogeneity in Pediatric Mixed Phenotype Acute Leukemia
10.1186/s13073-023-01241-z · 2023 · External reference
Editorial: Molecular MRD Testing in Patients With Acute Myeloid Leukemia
10.1038/s41409-024-02493-y · 2025 · External reference
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines From the American Society of Transplantation and Cellular Therapy
10.1016/j.jtct.2022.06.005 · 2022 · External reference
Relapsed Pediatric Acute Myeloid Leukaemia: State‐of‐the‐Art in 2023
10.3324/haematol.2022.281106 · 2023 · External reference
Outcomes and Challenges Treating Pediatric Acute Myeloid Leukemia: A Retrospective Analysis of Patients Treated at the Fundacion Valle del Lili Between 2011 and 2020
10.1016/j.htct.2023.08.006 · 2024 · External reference
Pathologic, Cytogenetic, and Molecular Features of Acute Myeloid Leukemia With Megakaryocytic Differentiation: A Report From the Children's Oncology Group
10.1002/pbc.30251 · ExternalCitation · doi-reference
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
10.1007/s11912-024-01503-y · ExternalCitation · doi-reference
Outcomes and Challenges Treating Pediatric Acute Myeloid Leukemia: A Retrospective Analysis of Patients Treated at the Fundacion Valle del Lili Between 2011 and 2020
10.1016/j.htct.2023.08.006 · ExternalCitation · doi-reference
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines From the American Society of Transplantation and Cellular Therapy
10.1016/j.jtct.2022.06.005 · ExternalCitation · doi-reference
NUP98 Is Rearranged in 3.8% of Pediatric AML Forming a Clinical and Molecular Homogenous Group With a Poor Prognosis
10.1038/leu.2016.267 · ExternalCitation · doi-reference
Relapsed Acute Myeloid Leukemia in Children and Adolescents: Current Treatment Options and Future Strategies
10.1038/s41375-022-01619-9 · ExternalCitation · doi-reference
Genetics and Pathologic Landscape of Lineage Switch of Acute Leukemia During Therapy
10.1038/s41408-024-00983-2 · ExternalCitation · doi-reference
The Landscape of NUP98 Rearrangements Clinical Characteristics and Treatment Response From 1491 Acute Leukemia Patients
10.1038/s41408-024-01066-y · ExternalCitation · doi-reference
Editorial: Molecular MRD Testing in Patients With Acute Myeloid Leukemia
10.1038/s41409-024-02493-y · ExternalCitation · doi-reference
Integrative Genomic Analysis of Adult Mixed Phenotype Acute Leukemia Delineates Lineage Associated Molecular Subtypes
10.1038/s41467-018-04924-z · ExternalCitation · doi-reference
NUP98/NSD1 Characterizes a Novel Poor Prognostic Group in Acute Myeloid Leukemia With a Distinct HOX Gene Expression Pattern
10.1182/blood-2011-04-346643 · ExternalCitation · doi-reference
NUP98/NSD1 and FLT3/ITD Coexpression Is More Prevalent in Younger AML Patients and Leads to Induction Failure: A COG and SWOG Report
10.1182/blood-2014-04-570929 · ExternalCitation · doi-reference
Mechanistic Insights and Potential Therapeutic Approaches for NUP98‐Rearranged Hematologic Malignancies
10.1182/blood.2020007093 · ExternalCitation · doi-reference
The Menin‐MLL1 Interaction Is a Molecular Dependency in NUP98‐rearranged AML
10.1182/blood.2021012806 · ExternalCitation · doi-reference
Project EVOLVE: An International Analysis of Postimmunotherapy Lineage Switch, an Emergent Form of Relapse in Leukemia
10.1182/blood.2024026655 · ExternalCitation · doi-reference
Fusion Oncoproteins and Cooperating Mutations Define Disease Phenotypes in NUP98‐rearranged Leukemia
10.1182/blood.2025028993 · ExternalCitation · doi-reference
Acute Erythroid Leukemia Is Enriched in NUP98 Fusions: A Report From the Children's Oncology Group
10.1182/bloodadvances.2020002712 · ExternalCitation · doi-reference
Single‐cell RNA Sequencing Distinctly Characterizes the Wide Heterogeneity in Pediatric Mixed Phenotype Acute Leukemia
10.1186/s13073-023-01241-z · ExternalCitation · doi-reference
Relapsed Pediatric Acute Myeloid Leukaemia: State‐of‐the‐Art in 2023
10.3324/haematol.2022.281106 · ExternalCitation · doi-reference
Comprehensive Molecular and Clinical Characterization of NUP98 Fusions in Pediatric Acute Myeloid Leukemia
10.3324/haematol.2022.281653 · ExternalCitation · doi-reference
